Paper19257816
Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001.
Ryg J and 4 others. J Bone Miner Res, 2009. Cited by 230 papers, by iCite.
Cite this record
ConductScience Library. Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. Papers, record 19257816. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19257816
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hip Fractures | Major topic |
| Registries | Major topic |
| Age Factors | |
| Aged | |
| Aged, 80 and over | |
| Denmark | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Risk Factors | |
| Sex Factors |
Source PubMed
Cited by144
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 230 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42496349 | Overall and Relative Survival After a Second Contralateral Hip Fracture in Adults over 65 Years: A Retrospective Cohort Study. | Geriatrics (Basel) | 2026 | https://conductscience.org/library/papers/42496349 | PubMed |
| 42393613 | Risk factors and early onset predictors of contralateral hip fractures following initial treatment of the other hip fracture. | BMC Musculoskelet Disord | 2026 | https://conductscience.org/library/papers/42393613 | PubMed |
| 41906827 | Predisposing factors for contralateral hip fractures in elderly patients over 80 years old. | Jt Dis Relat Surg | 2026 | https://conductscience.org/library/papers/41906827 | PubMed |
| 41816090 | Identification of factors predictive of contralateral secondary hip fractures in patients after initial hip fracture - A prospective observational study. | Bone Rep | 2026 | https://conductscience.org/library/papers/41816090 | PubMed |
| 41488884 | The minimally invasive surgical local osteo-enhancement procedure (LOEP) to deliver a resorbable, tri-phasic calcium-based implant material to address bone loss and strengthen the proximal femur. | Front Surg | 2025 | https://conductscience.org/library/papers/41488884 | PubMed |
| 41375797 | Risk Factors for Recurrent Fractures in Hip Fracture Patients: A Big Data Analysis of Demographic, Clinical, and Functional Characteristics. | J Clin Med | 2025 | https://conductscience.org/library/papers/41375797 | PubMed |
| 41168765 | Treatment with denosumab reduces second hip fracture risk in elderly patients with osteoporotic femoral neck fractures. | BMC Musculoskelet Disord | 2025 | https://conductscience.org/library/papers/41168765 | PubMed |
| 40921943 | The 2024 UK clinical guideline for the prevention and treatment of osteoporosis. | Arch Osteoporos | 2025 | https://conductscience.org/library/papers/40921943 | PubMed |
| 40900745 | Risk factors and predictors of contralateral hip fracture after surgical treatment in elderly patients. | Front Aging | 2025 | https://conductscience.org/library/papers/40900745 | PubMed |
| 40316583 | Multimodal sensor dataset for monitoring older adults post lower limb fractures in community settings. | Sci Data | 2025 | https://conductscience.org/library/papers/40316583 | PubMed |
| 39920732 | Efficacy and safety of sequential therapy for primary osteoporosis with bone formation promoters followed by bone resorption inhibitors: a meta-analysis. | J Orthop Surg Res | 2025 | https://conductscience.org/library/papers/39920732 | PubMed |
| 39857698 | Between Consecutive Fractures: Time and Sex as Dominant Factors in Type and Severity Concordance of Contralateral Hip Injuries. | Biomedicines | 2025 | https://conductscience.org/library/papers/39857698 | PubMed |
| 38977437 | Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials. | J Bone Miner Metab | 2024 | https://conductscience.org/library/papers/38977437 | PubMed |
| 38929545 | The Characteristics and Outcomes of Contralateral Non-Concurrent Hip Fractures: A Retrospective Study in Geriatric Patients. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/38929545 | PubMed |
| 38906978 | Analysis of the clinical characteristics and risk factors associated with contralateral hip fracture after initial hip fracture in elderly patients: a retrospective cohort study. | Sci Rep | 2024 | https://conductscience.org/library/papers/38906978 | PubMed |
| 38867268 | Risk factors for subsequent fractures in hip fracture patients: a nested case-control study. | J Orthop Surg Res | 2024 | https://conductscience.org/library/papers/38867268 | PubMed |
| 38858454 | Risk analysis for subsequent fracture of osteoporotic fractures in Chinese women over age 60: a nationwide cross-sectional study. | Sci Rep | 2024 | https://conductscience.org/library/papers/38858454 | PubMed |
| 38806800 | [Update of the S3-guideline on diagnostics, prophylaxis and treatment of osteoporosis]. | Orthopadie (Heidelb) | 2024 | https://conductscience.org/library/papers/38806800 | PubMed |
| 38526813 | [Secondary fracture prevention/Update osteoporosis guidelines 2023 of the Umbrella Organization Osteology]. | Unfallchirurgie (Heidelb) | 2024 | https://conductscience.org/library/papers/38526813 | PubMed |
| 38448782 | The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study. | Osteoporos Int | 2024 | https://conductscience.org/library/papers/38448782 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19257816
GET https://conductscience.org/api/papers/v1/19257816/cited_by?page=2